Twitter Beğeni Hilesi

Adult-onset Still disease - By Prunelle Getten (fellow in Internal Medicine, Paris, France) #Still #AOSD #InternistAcademy 2020

No more AKI in patients who received vancomycin and pipe-tazobactam compared to patients receiving cefepime and vancomycin. Is really vancomycin + piperacillin-tazobactam synergistically nephrotoxic? I don’t think so and we have more data to support that. Coming soon

Vancomycin (VN) and piperacillin-tazobactam (PT) are two antibiotics that provide broad antibacterial coverage in patients hospitalized for serious infections. This study investigates whether there is synergistic nephrotoxicity between VN and PT bit.ly/KID0432